SCHEMBL21856005

SCHEMBL21856005

COCCNc1nccc(I)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 2/20 0.46
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LDHA P00338 1/20 0.42
MAPK1 P28482 2/20 0.39
HIF1A Q16665 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP1A2 P05177 4/20 0.39
CYP2C19 P33261 3/20 0.39
CYP3A4 P08684 2/20 0.39
CLK4 Q9HAZ1 2/20 0.39
LMNA P02545 3/20 0.38
HTT P42858 2/20 0.38
HSD17B10 Q99714 3/20 0.38
ALOX15 P16050 1/20 0.38
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
CDC7 O00311 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21856112 0.81 UTS2R (0.46) UTS2RALDH1A1KDM4ESMN1; SMN2LDHA
SCHEMBL21855929 0.79 TNF (0.42) KDM4EMAPK1CYP3A4LMNAHTT
SCHEMBL22499429 0.78 UTS2R (0.40) UTS2RALDH1A1KDM4ECYP1A2LMNA
SCHEMBL16506402 0.75 UTS2R (0.44) UTS2RALDH1A1KDM4ESMN1; SMN2LDHA
SCHEMBL30133420 0.74 CLK4 (0.50) ALDH1A1KDM4ENPC1CLK4HTT
SCHEMBL27082684 0.74 CLK4 (0.50) ALDH1A1KDM4ENPC1CLK4HTT
SCHEMBL21856114 0.73 SMN1; SMN2 (0.48) UTS2RALDH1A1KDM4ESMN1; SMN2LDHA
SCHEMBL22440558 0.72 KDM4E (0.39) ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL15584960 0.72 LDHA (0.39) UTS2RALDH1A1KDM4ESMN1; SMN2LDHA
SCHEMBL21855993 0.70 UTS2R (0.41) UTS2RALDH1A1KDM4ESMN1; SMN2LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066357-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2025-02-27 US disclosed
US-12187721-B2 Protein tyrosine phosphatase inhibitors ARRAY BIOPHARMA INC. (US) 2025-01-07 US disclosed
CN-114341124-B Protein tyrosine phosphatase inhibitors ARRAY生物制药公司 2024-09-20 CN disclosed
EP-3867238-B1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC (US) 2023-06-07 EP disclosed
CN-114341124-A Protein tyrosine phosphatase inhibitors ARRAY生物制药公司 2022-04-12 CN disclosed
US-20210380582-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2021-12-09 US disclosed
WO-2020081848-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066357-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PPM1F, PPP5C UTS2R 1881/4885ALDH1A1 1850/4885KDM4E 1695/4885
US-12187721-B2 Protein tyrosine phosphatase inhibitors PPM1A, PTP4A1, PPP5C UTS2R 2056/4885ALDH1A1 1775/4885KDM4E 1572/4885
US-20210380582-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PTP4A1, PPP5C UTS2R 2056/4885ALDH1A1 1775/4885KDM4E 1572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.